Real-time enrollment status for this myeloproliferative neoplasms clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 8:58 AM UTC
| NCT Number | NCT07008118 |
| Recruiting Status | Recruiting |
| Condition | Myeloproliferative Neoplasms |
| Phase | PHASE1 |
| Target Enrollment | 120 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Incyte Corporation |
| Last Updated on CT.gov | August 6, 2026 (3 weeks ago) |
As of August 29, 2026: Clinical trial NCT07008118 is currently recruiting participants. This phase1 study for myeloproliferative neoplasms is actively seeking new participants at 12 locations across the United States. The study is sponsored by Incyte Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07008118 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07008118 was last updated 3 weeks ago (August 6, 2026). HelloStudys verifies this status automatically.